Investors / NSV
NSV
Venture capital
NSV describes itself as built by founders, scientists, and investors, and says it partners with ambitious teams for the long-haul. The firm states it works on advancing technology and medicine and connecting ideas, talent, and markets across borders.
Invests inHealthcare & Biotech
In its own wordstechnologymedicinelife scienceshealthcaredeep tech
Your fit with NSV
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsNSV lists 14 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (79%), Cybersecurity (7%) and AI & Machine Learning (7%). 67% of its companies are based in United States. It invests most often alongside NEA, Casdin Capital and Lux Capital.
No funding round on record names NSV yet, so the figures come from its portfolio page.
Round figures show recent activity, not NSV's whole history. Rounds on record name 0 companies; its own site lists 14. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 36th | 14 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 93th | 79% in its largest sector |
| Reach | 70th | 4 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers14100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 79% | 15% |
| Cybersecurity | 7% | 4% |
| AI & Machine Learning | 7% | 18% |
| Food & Agriculture | 7% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare NSV head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
14 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| BiomX Inc is now Tessera Defense and Homeland Security Inc, which provides an autonomous physical security platform | CybersecurityAI & Machine Learning | Portfolio page | ||
| Portfolio page | ||||
| Portfolio page | ||||
| Bota Bio produces bio-preservatives, nutritional supplements, and clean label products for the food and nutrition industries | Food & AgricultureHealthcare & Biotech | Portfolio page | ||
| Cognito Health is a predictive, contact-free and continuous monitoring system that can help reduce patient falls and pressure injuries. | Healthcare & Biotech | Portfolio page | ||
| Eligo Bioscience edits the microbiome gene repertoire in vivo | Healthcare & Biotech | Portfolio page | ||
| Lunit develops medical AI software for cancer detection and precision oncology | Healthcare & Biotech | Portfolio page | ||
| Medra develops and provides a robotic system that executes scientific protocols autonomously | Healthcare & Biotech | Portfolio page | ||
| NSG Bio offers co-working laboratory and office spaces for life sciences companies | Healthcare & Biotech | Portfolio page | ||
| OpenProtein provides tools and AI infrastructure for protein design | Healthcare & Biotech | Portfolio page | ||
| Protuoso Biosciences engineers multifunctional protein architectures for therapeutic use | Healthcare & Biotech | Portfolio page | ||
| Senti Bio is a clinical-stage company developing a new generation of cell and gene therapies for patients living with incurable diseases. | Healthcare & Biotech | Portfolio page | ||
| Synlogic designs and develops synthetic biotherapeutics to treat diseases | Healthcare & Biotech | Portfolio page | ||
| The company is developing medicines that target specific tumors using the principle of synthetic lethality. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- nsv.bio
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 14
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get NSV's profile as data
Pull NSV's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/nsv.bio
# also
GET /v1/firms/nsv.bio/portfolio
GET /v1/firms/nsv.bio/coinvestors
GET /v1/firms/nsv.bio/news